Page 766 - ACCCN's Critical Care Nursing

Pregnancy and Postpartum Considerations 743

82. The Magpie Trial Group. Do women with pre-eclampsia, and their babies, 108. Fung Kee Fung K, Eason E, Crane J, Armson A, De La Ronde S et al.
benefit from magnesium sulphate? The Magpie Trial: a randomised placebo- Prevention of Rh alloimmunization. J Obstet Gynaecol Canada 2003; 25(9):
controlled trial. Lancet 2002; 359(9321): 1877–90. 765–73.
83. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high 109. Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. Int J of Obstetric
blood pressure during pregnancy. Cochrane Database of Systematic Reviews Anesthesia 2008; 17(1): 37–45.
2006. CD001449. 110. King M, Wrench I, Galimberti A, Spray R. Introduction of cell salvage to a
84. Rugarn O, Moen S, Berg G. Eclampsia at a tertiary hospital 1973–99. Acta large obstetric unit: the first six months. Int J of Obstetric Anesthesia 2009;
Obstetricia et Gynecologica Scandinavica 2004; 83(3): 240–45. 18(2): 111–17.
85. Ganzevoort W, Rep A, Bonsel GJ, Fetter WPF, van Sonderen L et al. A ran- 111. Catling S. Blood conservation techniques in obstetrics: a UK perspective.
domised controlled trial comparing two temporising management strategies, Int J of Obstetric Anesthesia 2007; 16(3): 241–9.
one with and one without plasma volume expansion, for severe and early 112. Clark S. Amniotic fluid embolism. Clinical Obstetrics and Gynecology 2010;
onset pre-eclampsia. BJOG 2005; 112(10): 1358–68. 53(2): 322–8.
86. Dildy GA, Belfort MA, Saade GR, Phelan JP, Hankins GD, Clark SL, 113. Tuffnell DJ, Hamilton S. Amniotic fluid embolism. Obstetrics, Gynaecology &
eds. Critical care obstetrics, 4th edn. Massachusetts: Blackwell Science; Reproductive Medicine 2008; 18(8): 213–16.
2004. 114. Shechtman M, Ziser A, Markovits R, Rozenberg B. Amniotic fluid embolism:
87. Smith CV, Phelan JP. Determinants for invasive monitoring in severe pre- early findings of transesophageal echocardiography. Anesth Analg 1999;
eclampsia, Contemporary Obstetrics and Gynaecology 1986, January, 109–124. 89(6): 1456–8.
88. Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for 115. Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based
HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in preg- review. Am J Obstet Gynecol 2009; 201(445): e1–13.
nancy. Cochrane Database of Systematic Reviews 2010. CD008148. 116. Knight M, Tuffnell D, Brocklehurst P, Spark P, Kurinczuk JJ on behalf of
89. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung the UKOSS. Incidence and risk factors for amniotic-fluid embolism. Obstet-
maturation for women at risk of preterm birth. Cochrane Database of System- rics & Gynecology 2010; 115(5): 910–17.
atic Reviews 2006. CD004454. 117. Aguillon A, Andjus T, Grayson A, Race GJ. Amniotic Fluid Embolism:
90. Visser W, Wallenburg HCS. Maternal and perinatal outcome of temporizing A Review. Obstetrical & Gynecological Survey 1962; 17(5): 619–36.
management in 254 consecutive patients with severe pre-eclampsia remote 118. Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors
from term. Euro J Obstetrics & Gynecology and Reproductive Biology 1995; 63(2): of amniotic fluid embolisms: a population-based study on 3 million births
147–54. in the United States. Am J Obstetrics and Gynecology 2008; 199(1): e41–49.
91. Cameron CA, Roberts CL, Olive EC, Ford JB, Fischer WE. Trends in postpar- 119. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM et al. Peripartum
tum haemorrhage. Aust NZ J Public Health 2006; 30(2): 151–6. cardiomyopathy: National Heart, Lung, and Blood Institute and Office of
92. 3 Centres Collaboration. Antepartum haemorrhage clinical practice guidelines Rare Diseases (National Institutes of Health) Workshop Recommendations
2010. [Cited December 2010]. Available at: http://3centres.com.au/library/ and Review. JAMA 2000; 283(9): 1183–8.
public/file/guidelines/Complications_in_Pregnancy_and_Birth/Antepar 120. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B et al. Current
tum_Haemorrhage.pdf. state of knowledge on aetiology, diagnosis, management, and therapy of
93. Bretelle F, Courbiere B, Mazouni C, Agostini A, Cravello L et al. Management peripartum cardiomyopathy: A position statement from the Heart Failure
of placenta accreta: Morbidity and outcome. Euro J Obstetrics & Gynecology Association of the European Society of Cardiology Working Group on peri-
and Reproductive Biology 2007; 133(1): 34–9. partum cardiomyopathy. Euro J Heart Failure 2010; 12(8): 767–78.
94. Ford JB, Roberts CL, Simpson JM, Vaughan J, Cameron CA. Increased 121. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;
postpartum hemorrhage rates in Australia. Int J Gynecology & Obstetrics 2007; 368(9536): 687–93.
98(3): 237–43. 122. Ntusi N, Mayosi B. Aetiology and risk factors of peripartum cardiomyopathy:
95. Henry A, Birch MR, Sullivan EA, Katz S, Wang YPA. Primary postpartum a systematic review. Int J of Cardiology 2009; 131(2), 168–79.
haemorrhage in an Australian tertiary hospital: a case-control study. Aust NZ 123. Cruz M, Briller M, Hibbard J. Update on peripartum cardiomyopathy. Obstet
J of Obstetrics & Gynaecology 2005; 45(3): 233–6. Gynecol Clin N Am 2010; 37(2): 283–303.
96. Roberts CL, Ford J, Algert CS, Bell J, Simpson JM, Morris JM. Trends 124. Mielniczuk LM, Williams K, Davis DR, Tang ASL, Lemery R et al. Frequency
in adverse maternal outcomes during childbirth: a population-based study of peripartum cardiomyopathy. Am J of Cardiology 2006; 97(12): 1765–8.
of severe maternal morbidity. BMC Pregnancy and Childbirth 2009; 125. Fett JD, Sannon H, Thélisma E, Sprunger T, Suresh V. Recovery from severe
9(1): 7. heart failure following peripartum cardiomyopathy. Int J of Gynecology &
97. Brace V, Kernaghan D, Penney G. Learning from adverse clinical outcomes: Obstetrics 2009; 104(2): 125–7.
major obstetric haemorrhage in Scotland, 2003–05. BJOG 2007, 114(11): 126. Egan DJ, Bisanzo MC, Hutson HR Emergency Department Evaluation and
1388–96. Management of Peripartum Cardiomyopathy. Emerg Med 2009; 36(2):
98. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. 141–7.
Cochrane Database of Systematic Reviews 2007. CD003249. 127. Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy: recent
99. Lapinsky S, Kruczynski K, Seaward G, Farine D, Grossman R. Critical care insights in its pathophysiology. Trends in Cardiovascular Medicine 2008;
management of the obstetric patient. Canadian Journal of Anaesthesia 1997; 18(5): 173–9.
44(3): 3259. 128. Ichida M, Katsurada K, Komori T, Matsumoto J, Ohkuchi A et al. Effective-
100. Campbell L, Klocke R. Implications for the Pregnant Patient. Am J Respir. ness of bromocriptine treatment in a patient with peripartum cardiomyopa-
Crit. Care Med, 2001; 163(5): 1051–4. thy. J Cardiology Cases 2010; 2(1): e28–31.
101. Huang WC, Chen CP. Pulmonary edema in pregnancy. Int J Gynecology and 129. Hilfiker-Kleiner D, Kaminski K, Podewski E et al. A cathepsin D-cleaved
Obstetrics 2002; 78(3): 241–3. 16-kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;
102. Chamberlain G, Steer P. ABC of labour care: Obstetric emergencies. BMJ 128(3): 589–600.
1999; 318(7194): 1342–5. 130. Hilfiker-Kleiner D, Meyer GP, Schieffer E et al. Recovery from postpartum
103. Letsky E. Coagulation defects. In: de Swiet M, ed. Medical disorders in obstetric cardiomyopathy in 2 patients by blocking prolactin release with bromocrip-
practice, 4th edn. Blackwell Publishing, Oxford; 2002. p. 61–96. tine. J Am Coll Cardiol 2007; 50(24): 2354–5.
104. Slaytor EK, Sullivan EA, King JF. Maternal deaths in Australia 1997–1999. 131. Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS et al. Maternal and
Sydney: AIHW National Perinatal Statistics Unit (Maternal Deaths Series No fetal outcomes of subsequent pregnancies in women with peripartum car-
1); 2004. diomyopathy. New Eng J Med 2001; 344(21): 1567–71.
105. Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA. A high 132. Kwon H, Belanger K, Bracken M. Asthma prevalence among pregnant and
ratio of plasma and platelets to packed red blood cells in the first 6 hours childbearing-aged women in the United States: Estimates from National
of massive transfusion improves outcomes in a large multicenter study. Am Health surveys. Annals of Epidemiology 2003; 13(5): 317–24.
J Surgery 2009, 197(5): 565–70. 133. Australian Centre for Asthma Monitoring. Asthma in Australia 2008. AIHW
106. Phillips L, McLintock C, Pollock W, Gatt S, Popham P et al. Recombinant Asthma Series no. 3. Canberra: Australian Institute of Health and Welfare;
activated Factor VII in obstetric hemorrhage: experiences from the Australian 2008.
and New Zealand haemostasis registry. Anesthesia and Analgesia 2009; 134. Juniper E, Newhouse M. Effect of pregnancy on asthma: A critical appraisal
109(6): 1908–15. of the literature. In: Schatz M, Zeiger RS, eds. Asthma and allergy in pregnancy
107. Wang HY, Chang CT, Wu MS. Postpartum hemorrhage complicated with and early infancy. New York: Marcel Dekker; 1993. p. 223–49.
irreversible renal failure and central diabetes insipidus. Renal Failure 2002; 135. Beecroft N, Cochrane GM, Milburn HJ. Effect of sex of fetus on asthma
24(6): 849–52. during pregnancy: blind prospective study. BMJ 1998; 317(7162): 856–7.